Literature DB >> 33717010

Antimicrobial Photodynamic Therapy Combined With Antibiotic in the Treatment of Rats With Third-Degree Burns.

Zhanjuan Zhao1,2, Jinduo Ma3, Yiyi Wang4, Zehua Xu5, Lu Zhao6, Jianxi Zhao7, Ge Hong2, Tianjun Liu2.   

Abstract

Cationic porphyrin conjugate, protoporphyrin IX-methyl ethylenediamine derivative (PPIX-MED) has a potent photosensitive antibacterial effect on clinically isolated bacteria, including methicillin-resistant Staphylococcus aureus, (MRSA), Escherichia coli, and Pseudomonas aeruginosa. This study investigated (i) the PPIX-MED-mediated antimicrobial photodynamic effect on these three species in vitro and (ii) the effect of antimicrobial photodynamic therapy (aPDT) combined with the use of an antibiotic on the healing in vivo of third-degree burns of rats with the wounds infected by these bacterial species. PPIX-MED exerted a potent inhibitory effect on the growth of the three bacterial species by producing reactive oxygen species when photoactivated. PPIX-MED-mediated antimicrobial photodynamic therapy (PPIX-MED-aPDT) had high bacterial photoinactivation ability in vitro, with a minimum inhibitory concentration of 15.6 μM PPIX-MED against each of the three types of bacteria and minimum bactericidal concentrations of 31.25 μM against MRSA and E. coli and 62.5 μM against P. aeruginosa. In rats with third-degree burns infected by a mixture of these bacteria, the bactericidal efficiency of PPIX-MED-aPDT-combined-with-antibiotic treatment was higher than that of antibiotic or aPDT treatment alone. This was confirmed by analysis of viable bacterial counts in wound tissue and blood. Enzyme-linked immunosorbent assay revealed that aPDT-combined-with-antibiotic treatment resulted in an obvious reduction in tumor necrosis factor-alpha and interleukin-6 levels compared with the no-treatment control group and the other treatment groups. Immunohistochemistry revealed that the expression of basic fibroblast growth factor and CD31 (a marker of neovascularization), expressed in burn wound tissue was higher in the aPDT-combined-with-antibiotic treatment group than in the other groups. PPIX-MED-aPDT has a promising bactericidal effect both in vitro and in vivo, and PPIX-MED-aPDT-combined-with-antibiotic treatment enhanced the healing of infected third-degree burns in rats.
Copyright © 2021 Zhao, Ma, Wang, Xu, Zhao, Zhao, Hong and Liu.

Entities:  

Keywords:  antimicrobial effect; antimicrobial photodynamic therapy; burned; cationic porphyrins; photosensitizer; rats

Year:  2021        PMID: 33717010      PMCID: PMC7943878          DOI: 10.3389/fmicb.2021.622410

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  46 in total

1.  A new glycosidation method through nitrite displacement on substituted nitrobenzenes.

Authors:  Xavier Alvarez-Micó; Mario J F Calvete; Michael Hanack; Thomas Ziegler
Journal:  Carbohydr Res       Date:  2006-11-21       Impact factor: 2.104

2.  Photodynamic inactivation of primary human fibroblasts by methylene blue and toluidine blue O.

Authors:  Nasim Kashef; Gita Ravaei Sharif Abadi; Gholamreza Esmaeeli Djavid
Journal:  Photodiagnosis Photodyn Ther       Date:  2012-06-26       Impact factor: 3.631

3.  Histological evaluation of the safety of toluidine blue-mediated photosensitization to periodontal tissues in mice.

Authors:  X L Luan; Y L Qin; L J Bi; C Y Hu; Z G Zhang; J Lin; C N Zhou
Journal:  Lasers Med Sci       Date:  2008-02-01       Impact factor: 3.161

Review 4.  Antimicrobial photodynamic therapy to kill Gram-negative bacteria.

Authors:  Felipe F Sperandio; Ying-Ying Huang; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-08

5.  Protective properties of kefir on burn wounds of mice that were infected with S. aureus, P. auroginasa and E. coli.

Authors:  Songul Cetik Yildiz; Cemil Demir; Mustafa Cengiz; Adnan Ayhanci
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2019-09-30       Impact factor: 1.770

6.  Susceptibility of methicillin-resistant Staphylococcus aureus to photodynamic antimicrobial chemotherapy with α-D-galactopyranosyl zinc phthalocyanines: in vitro study.

Authors:  Zhanjuan Zhao; Yanzhou Li; Shuai Meng; Shaozeng Li; Qiong Wang; Tianjun Liu
Journal:  Lasers Med Sci       Date:  2013-11-19       Impact factor: 3.161

7.  Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.

Authors:  Yali Zhang; Dandan Liang; Lili Dong; Xiangting Ge; Fengli Xu; Wenbo Chen; Yuanrong Dai; Huameng Li; Peng Zou; Shulin Yang; Guang Liang
Journal:  Respir Res       Date:  2015-03-24

8.  Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE.

Authors:  Anima Nanda; M Saravanan
Journal:  Nanomedicine       Date:  2009-02-13       Impact factor: 5.307

9.  Photodynamic antimicrobial chemotherapy for Staphylococcus aureus and multidrug-resistant bacterial burn infection in vitro and in vivo.

Authors:  Bingjie Mai; Yiru Gao; Min Li; Xiaobing Wang; Kun Zhang; Quanhong Liu; Chuanshan Xu; Pan Wang
Journal:  Int J Nanomedicine       Date:  2017-08-17

10.  In Vitro Bactericidal Effects of Photodynamic Therapy Combined with Four Tetracyclines against Clostridioides difficile KCTC5009 in Planktonic Cultures.

Authors:  Sung Sook Choi; Hui Yeong Oh; Eui Jin Kim; Hae Kyung Lee; Hyung Keun Kim; Hyun Ho Choi; Sang Woo Kim; Hiun Suk Chae
Journal:  Pathogens       Date:  2020-04-11
View more
  2 in total

1.  Antimicrobial Photodynamic Therapy Involving a Novel Photosensitizer Combined With an Antibiotic in the Treatment of Rabbit Tibial Osteomyelitis Caused by Drug-Resistant Bacteria.

Authors:  Xiujuan Yin; Ziyuan Fang; Yan Fang; Lin Zhu; Jinwen Pang; Tianjun Liu; Zhanjuan Zhao; Jianxi Zhao
Journal:  Front Microbiol       Date:  2022-04-22       Impact factor: 6.064

Review 2.  Applications of Antimicrobial Photodynamic Therapy against Bacterial Biofilms.

Authors:  Sandile Phinda Songca; Yaw Adjei
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.